chr7-150945388-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_000238.4(KCNH2):c.3457C>T(p.His1153Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.0000729 in 1,590,340 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H1153Q) has been classified as Uncertain significance.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000078 ( 0 hom. )
Consequence
KCNH2
NM_000238.4 missense
NM_000238.4 missense
Scores
6
7
6
Clinical Significance
Conservation
PhyloP100: 4.75
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAdExome4 at 112 AD,Digenic gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.3457C>T | p.His1153Tyr | missense_variant | 15/15 | ENST00000262186.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.3457C>T | p.His1153Tyr | missense_variant | 15/15 | 1 | NM_000238.4 | P1 | |
KCNH2 | ENST00000330883.9 | c.2437C>T | p.His813Tyr | missense_variant | 11/11 | 1 | |||
KCNH2 | ENST00000684241.1 | n.4290C>T | non_coding_transcript_exon_variant | 13/13 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000483 AC: 10AN: 207056Hom.: 0 AF XY: 0.0000623 AC XY: 7AN XY: 112290
GnomAD3 exomes
AF:
AC:
10
AN:
207056
Hom.:
AF XY:
AC XY:
7
AN XY:
112290
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000779 AC: 112AN: 1438114Hom.: 0 Cov.: 31 AF XY: 0.0000940 AC XY: 67AN XY: 713072
GnomAD4 exome
AF:
AC:
112
AN:
1438114
Hom.:
Cov.:
31
AF XY:
AC XY:
67
AN XY:
713072
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74380
GnomAD4 genome
AF:
AC:
4
AN:
152226
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:7Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Long QT syndrome 2 Pathogenic:1Uncertain:1Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | KardioGenetik, Herz- und Diabeteszentrum NRW | Oct 18, 2023 | - - |
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpretted as Uncertain significance and reported on 10-10-2018 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Likely pathogenic, no assertion criteria provided | clinical testing | Research Institute, Imperial College London Diabetes Centre | Jan 24, 2021 | The c.3457 C>T p.(His1153Tyr) variant detected in heterozygosity in the KCNH2 gene, is described in the literature in one patient with Long QT syndrome (PMID: 16414944) and in a case of sudden death (PMID: 26164358). This variant has been identified in population databases dbSNP (rs199473035), gnomAD with allele frequency (AF) of 0.00483%, exome aggregation consortium (ExAC) with AF of 0.00019 and absent in the database ESP. This rare variant is located in a moderately conserved residue in the distal C-terminus domain of the KCNH2 protein. Computational prediction tools and conservation analyses suggest that this variant may have a deleterious impact on the protein function (ClinVar ). Bioinformatics tools do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Therefore, it has been classified as a variant of uncertain clinical significance in ClinVar (Variation ID: 67497). Additionally, this variant was described in a German doctoral thesis in a male patient with atypical atrial flutter alternating with typical atrial flutter and paroxysmal atrial fibrillation. The functional characterization of the H1153Y channel variant in Xenopus oocytes showed a loss of function and no dominant negative effect on wild-type (WT) channels (Limberg, M., 2011). These results concur with a recent study that identified this H1153Y KCNH2 variant in a sudden arrhythmic death syndrome case. The study showed that the H1153Y variant causes a loss of KCNH2 channel function that reduces the current density leading to LQT2. (Farrugia, A. et al., 2021). - |
Long QT syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Feb 05, 2024 | This missense variant replaces histidine with tyrosine at codon 1153 of the KCNH2 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). A functional study with cell culture system has shown that this variant causes a reduction in the channel current density, without apparent impact on channel trafficking to the cell membrane (PMID: 34502138). This variant has been reported in an individual affected with long QT syndrome (PMID: 16414944) and in an individual affected with sudden death (PMID: 26164358). This variant has been identified in 10/207056 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 1153 of the KCNH2 protein (p.His1153Tyr). This variant is present in population databases (rs199473035, gnomAD 0.009%). This missense change has been observed in individual(s) with long QT syndrome (PMID: 16414944, 26164358, 34502138). ClinVar contains an entry for this variant (Variation ID: 67497). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 34502138). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 13, 2021 | Reported in an individual with LQTS (Napolitano et al., 2005) and in an individual with sudden unexplained death while exercising (Farrugia et al., 2015); Reported in ClinVar as a variant of uncertain significance (ClinVar Variant ID# 67497; Landrum et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32048431, 22581653, 26164358, 16414944, 19862833) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2023 | The p.H1153Y variant (also known as c.3457C>T), located in coding exon 15 of the KCNH2 gene, results from a C to T substitution at nucleotide position 3457. The histidine at codon 1153 is replaced by tyrosine, an amino acid with similar properties. This alteration has been reported in long QT syndrome genetic testing cohorts (Napolitano C et al. JAMA, 2005 Dec;294:2975-80; Walsh R et al. Genet Med, 2021 Jan;23:47-58). Additionally, this alteration was detected in a sudden unexplained death cohort, and an in vitro assay showed it may impact protein function (Farrugia A et al. Forensic Sci. Int., 2015 Sep;254:5-11; Farrugia A et al. Int J Mol Sci, 2021 Aug;22:[ePub ahead of print]). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Short QT syndrome type 1;C3150943:Long QT syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 23, 2021 | - - |
Cardiac arrhythmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 21, 2023 | This missense variant replaces histidine with tyrosine at codon 1153 of the KCNH2 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). A functional study with cell culture system has shown that this variant causes a reduction in the channel current density, without apparent impact on channel trafficking to the cell membrane (PMID: 34502138). This variant has been reported in an individual affected with long QT syndrome (PMID: 16414944) and in an individual affected with sudden death (PMID: 26164358). This variant has been identified in 10/207056 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:16414944). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Benign
.;L
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
T
PROVEAN
Benign
N;N
REVEL
Pathogenic
Sift
Benign
D;D
Sift4G
Uncertain
D;D
Polyphen
P;D
Vest4
MutPred
0.73
.;Gain of phosphorylation at H1153 (P = 0.0376);
MVP
MPC
0.59
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at